Treatment of pre- and post-liver transplantation HBV infection: Should we aim at combination therapy?

被引：16

作者：

Zoulim, F

机构：

[1] INSERM, U271, F-69003 Lyon, France

[2] Hop Hotel Dieu, Liver Dept, Lyon, France

来源：

HEPATOLOGY | 2003年 / 38卷 / 06期

关键词：

D O I：

10.1016/j.hep.2003.10.001

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：1353 / 1355

页数：3

共 26 条

[1] Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase [J].

Angus, P ;

Vaughan, R ;

Xiong, S ;

Yang, HL ;

Delaney, W ;

Gibbs, C ;

Brosgart, C ;

Colledge, D ;

Edwards, R ;

Ayres, A ;

Bartholomeusz, A ;

Locarnini, S .

GASTROENTEROLOGY, 2003, 125 (02) :292-297

[2] Safety and efficacy of adefovir dipivoxil in patients co-infected with HIV-1 and lamivudine-resistant hepatitis B virus: an open-label pilot study [J].

Benhamou, Y ;

Bochet, M ;

Thibault, V ;

Calvez, V ;

Fievet, MH ;

Vig, P ;

Gibbs, CS ;

Brosgart, C ;

Fry, J ;

Namini, H ;

Katiama, C ;

Poynard, T .

LANCET, 2001, 358 (9283) :718-723

[3] A randomized study comparing lamivudine monotherapy after a short course of hepatitis B immune globulin (HBIg) and lamivudine with long-term lamivudine plus HBIg in the prevention of hepatitis B virus recurrence after liver transplantation [J].

Buti, M ;

Mas, A ;

Prieto, M ;

Casafont, F ;

Gonzalez, A ;

Miras, M ;

Herrero, JI ;

Jardí, R ;

de Castro, EC ;

García-Rey, C .

JOURNAL OF HEPATOLOGY, 2003, 38 (06) :811-817

[4] New targets and possible new therapeutic approaches in the chemotherapy of chronic hepatitis B [J].

Feld, J ;

Lee, JY ;

Locarnini, S .

HEPATOLOGY, 2003, 38 (03) :545-553

[5] Sensitivity of L-(-)2′,3′-dideoxythiacytidine resistant hepatitis B virus to other antiviral nucleoside analogues [J].

Fu, L ;

Liu, SH ;

Cheng, YC .

BIOCHEMICAL PHARMACOLOGY, 1999, 57 (12) :1351-1359

[6] Prevalence and clinical correlates of YMDD variants during lamivudine therapy for patients with chronic hepatitis B [J].

Lai, CL ;

Dienstag, J ;

Schiff, E ;

Leung, NWY ;

Atkins, M ;

Hunt, C ;

Brown, N ;

Woessner, M ;

Boehme, R ;

Condreay, L .

CLINICAL INFECTIOUS DISEASES, 2003, 36 (06) :687-696

[7] Efficacies of entecavir against lamivudine-resistant hepatitis B virus replication and recombinant polymerases in vitro [J].

Levine, S ;

Hernandez, D ;

Yamanaka, G ;

Zhang, S ;

Rose, R ;

Weinheimer, S ;

Colonno, RJ .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (08) :2525-2532

[8] PRETRANSPLANTATION INTERFERON TREATMENT AND RECURRENCE OF HEPATITIS-B VIRUS-INFECTION AFTER LIVER-TRANSPLANTATION FOR HEPATITIS-B RELATED END-STAGE LIVER-DISEASE [J].

MARCELLIN, P ;

SAMUEL, D ;

AREIAS, J ;

LORIOT, MA ;

ARULNADEN, JL ;

GIGOU, M ;

DAVID, MF ;

BISMUTH, A ;

REYNES, M ;

BRECHOT, C ;

BENHAMOU, JP ;

BISMUTH, H .

HEPATOLOGY, 1994, 19 (01) :6-12

[9] Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B [J].

Marcellin, P ;

Chang, T ;

Lim, SG ;

Tong, MJ ;

Sievert, W ;

Shiffman, ML ;

Jeffers, L ;

Goodman, Z ;

Wulfsohn, MS ;

Xiong, S ;

Fry, J ;

Brosgart, CL ;

Afdhal, N ;

O'Conner, C ;

Andreone, P ;

Cursaro, C ;

Angus, P ;

Vaughan, R ;

Bain, V ;

Gutfreund, K ;

Barange, K ;

Duffant, M ;

Barnes, E ;

Bennett, M ;

Pressman, J ;

Bernstein, D ;

Bonino, F ;

Coco, B ;

Borum, M ;

Schuck, S ;

Bourliere, M ;

Benali, S ;

Boyer, N ;

Castelnau, C ;

Brown, R ;

Scales, S ;

Buggisch, P ;

Peterson, J ;

Cooksley, G ;

MacDonald, G ;

Couzigou, P ;

Foucner, D ;

Crawford, D ;

Der, A ;

Desmond, P ;

Boussioutas, A ;

DiBisceglie, A ;

Bacon, B ;

Dieterich, D ;

Goldman, D .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (09) :808-816

[10] Selection of multiresistant hepatitis B virus during sequential nucleoside-analogue therapy [J].

Mutimer, D ;

Pillay, D ;

Cook, P ;

Ratcliffe, D ;

O'Donnell, K ;

Dowling, D ;

Shaw, J ;

Elias, E ;

Cane, PA .

JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (02) :713-716

← 1 2 3 →